Anixa Biosciences receives South Korean patent for breast cancer vaccine
Go back to Anixa Biosciences receives South Korean patent for breast cancer vaccine| (NASDAQ: ANIX) | Delayed: 2.60 -0.09 (3.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.69 | 52 Week High | $ | |||
| Open | $2.70 | 52 Week Low | $ | |||
| Day High | $2.72 | P/E | N/A | |||
| Day Low | $2.56 | EPS | $ | |||
| Volume | 557,485 | |||||

